Vitamin A Impairs the Reprogramming of Tregs into IL-17-Producing Cells during Intestinal Inflammation

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Tejón, Gabriela ^a   Manríquez, Valeria ^a   De Calisto, Jaime ^a,b   Flores Santibáñez, Felipe ^a   Hidalgo, Yessia ^a   Crisóstomo, Natalia ^a   Fernández, Dominique ^a   Sauma, Daniela ^a   Mora, J Rodrigo ^b   Bono, Mariá R ^a   Rosemblatt, Mario ^a,c,d  

^a UNIVERSITY OF CHILE   (Chile)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Fundacion Ciencia para la Vida   (Chile)

^d UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BIOLOGICAL MARKER; CD39 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 17; INTERLEUKIN 2; PROTEIN LAG3; RETINOIC ACID; RETINOL; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE MODEL; NONHUMAN; NUCLEAR REPROGRAMMING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL; ANIMAL; BIOSYNTHESIS; CELL LINEAGE; CELLULAR IMMUNITY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INTESTINE; METABOLISM; PATHOLOGY;

ANIMALS; CELL LINEAGE; CELLULAR REPROGRAMMING; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-2; INTESTINES; MICE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRETINOIN; VITAMIN A;

EID: 84947475176     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/137893     Document Type: Article

References (40)

1. G. Bouma and W. Strober, "The immunological and genetic basis of inflammatory bowel disease, " Nature Reviews Immunology, vol. 3, no. 7, pp. 521-533, 2003.
2. W. Strober, I. Fuss, and P. Mannon, "The fundamental basis of inflammatory bowel disease, " The Journal of Clinical Investigation, vol. 117, no. 3, pp. 514-521, 2007.
3. W. Strober, I. J. Fuss, and R. S. Blumberg, "The immunology of mucosal models of inflammation, " Annual Review of Immunology, vol. 20, pp. 495-549, 2002.
4. A. Bai, N. Lu, Y. Guo, Z. Liu, J. Chen, and Z. Peng, "Alltrans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis, " Journal of Leukocyte Biology, vol. 86, no. 4, pp. 959-969, 2009.
5. L. Zhang, Y. Zhang, W. Zhong, C. Di, X. Lin, and Z. Xia, "Heme oxygenase-1 ameliorates dextran sulfate sodium-induced acute murine colitis by regulatingTh17/Treg cell balance, " The Journal of Biological Chemistry, vol. 289, no. 39, pp. 26847-26858, 2014.
6. T. Olsen, R. Rismo, G. Cui, R. Goll, I. Christiansen, and J. Florholmen, "TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation, " Cytokine, vol. 56, no. 3, pp. 633-640, 2011.
7. M. F. Neurath, "Cytokines in inflammatory bowel disease, " Nature Reviews Immunology, vol. 14, no. 5, pp. 329-342, 2014.
8. S. Fujino, A. Andoh, S. Bamba et al., "Increased expression of interleukin 17 in inflammatory bowel disease, " Gut, vol. 52, no. 1, pp. 65-70, 2003.
9. C. O. Elson, Y. Cong, C. T. Weaver et al., "Monoclonal antiinterleukin 23 reverses active colitis in a T cell-mediated model in mice, " Gastroenterology, vol. 132, no. 7, pp. 2359-2370, 2007.
10. S. Read, V. Malmström, and F. Powrie, "Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation, " Journal of ExperimentalMedicine, vol. 192, no. 2, pp. 295-302, 2000.
11. J. L. Coombes, N. J. Robinson, K. J. Maloy, H. H. Uhlig, and F. Powrie, "Regulatory T cells and intestinal homeostasis, " Immunological Reviews, vol. 204, pp. 184-194, 2005.
12. A. Izcue, J. L. Coombes, and F. Powrie, "Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation, " Immunological Reviews, vol. 212, pp. 256-271, 2006.
13. H. H. Uhlig, J. Coombes, C. Mottet et al., "Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis, " The Journal of Immunology, vol. 177, no. 9, pp. 5852-5860, 2006.
14. C. Mottet, H. H. Uhlig, andF. Powrie, "Cutting edge: cureof colitis by CD4+CD25+ regulatory T cells, " Journal of Immunology, vol. 170, no. 8, pp. 3939-3943, 2003.
15. D. Mucida, Y. Park, G. Kim et al., "Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid, " Science, vol. 317, no. 5835, pp. 256-260, 2007.
16. M. J. Benson, K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle, "All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of costimulation, " The Journal of ExperimentalMedicine, vol. 204, no. 8, pp. 1765-1774, 2007.
17. J. L. Coombes, K. R. R. Siddiqui, C. V. Arancibia-Cárcamo et al., "A functionally specialized population ofmucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependentmechanism, " Journal of ExperimentalMedicine, vol. 204, no. 8, pp. 1757-1764, 2007.
18. C.-M. Sun, J. A. Hall, R. B. Blank et al., "Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid, " Journal of ExperimentalMedicine, vol. 204, no. 8, pp. 1775-1785, 2007.
19. S. Xiao, H. Jin, T. Korn et al., "Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression, " Journal of Immunology, vol. 181, no. 4, pp. 2277-2284, 2008.
20. H.-R. Cha, S.-Y. Chang, J.-H. Chang et al., "Downregulation of Th17 cells in the small intestine by disruption of gut flora in the absence of retinoic acid, " Journal of Immunology, vol. 184, no. 12, pp. 6799-6806, 2010.
21. Y. H. Van, W. H. Lee, S. Ortiz, M. H. Lee, H. J. Qin, and C. P. Liu, "All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affectingTh17 cells, " Diabetes, vol. 58, no. 1, pp. 146-155, 2009.
22. S. G. Zheng, J. Wang, P. Wang, J. D. Gray, and D. A. Horwitz, "IL-2 is essential for TGF- to convert naive CD4+CD25? cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells, " The Journal of Immunology, vol. 178, no. 4, pp. 2018-2027, 2007.
23. E. Bettelli, Y. Carrier, W. Gao et al., "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, " Nature, vol. 441, no. 7090, pp. 235-238, 2006.
24. E. Yurchenko, M. T. Shio, T. C. Huang et al., "Inflammationdriven reprogramming of CD4+foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo, " PLoS ONE, vol. 7, no. 4, Article ID e35572, 2012.
25. N. Komatsu, K. Okamoto, S. Sawa et al., "Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis, " Nature Medicine, vol. 20, no. 1, pp. 62-68, 2014.
26. J. R. Mora, M. R. Bono, N. Manjunath et al., "Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells, " Nature, vol. 424, no. 6944, pp. 88-93, 2003.
27. C. Moore, G. Tejon, C. Fuentes et al., "Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection, " European Journal of Immunology, vol. 45, no. 2, pp. 452-463, 2015.
28. X. Zhou, N. Kong, J. Wang et al., "Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu, " The Journal of Immunology, vol. 185, no. 5, pp. 2675-2679, 2010.
29. J. L. Napoli, "Physiological insights into all-trans-retinoic acid biosynthesis, " Biochimica et Biophysica Acta, vol. 1821, no. 1, pp. 152-167, 2012.
30. B. H. Nelson, "IL-2, regulatory T cells, and tolerance, " Journal of Immunology, vol. 172, no. 7, pp. 3983-3988, 2004.
31. A. Y. Rudensky, "Regulatory T cells and Foxp3, " Immunological Reviews, vol. 241, no. 1, pp. 260-268, 2011.
32. I. Kryczek, K. Wu, E. Zhao et al., "IL-17+ regulatory T Cells in the microenvironments of chronic inflammation and cancer, " Journal of Immunology, vol. 186, no. 7, pp. 4388-4395, 2011.
33. K. Hong, Y. Zhang, Y. Guo et al., "All-trans retinoic acid attenuates experimental colitis through inhibition of NF-B signaling, " Immunology Letters, vol. 162, no. 1, pp. 34-40, 2014.
34. R. Reifen, T. Nur, K. Ghebermeskel, G. Zaiger, R. Urizky, and M. Pines, "Vitamin A deficiency exacerbates inflammation in a ratmodel of colitis through activation of nuclear factor-kappaB and collagen formation, " Journal of Nutrition, vol. 132, no. 9, pp. 2743-2747, 2002.
35. S. Deaglio, K. M. Dwyer, W. Gao et al., "Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, " The Journal of Experimental Medicine, vol. 204, no. 6, pp. 1257-1265, 2007.
36. J. J. Kobie, P. R. Shah, L. Yang, J. A. Rebhahn, D. J. Fowell, and T. R. Mosmann, "T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5-adenosine monophosphate to adenosine, " Journal of Immunology, vol. 177, no. 10, pp. 6780-6786, 2006.
37. C. Oderup, L. Cederbom, A. Makowska, C. M. Cilio, and F. Ivars, "Cytotoxic T lymphocyte antigen-4-dependent downmodulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression, " Immunology, vol. 118, no. 2, pp. 240-249, 2006.
38. B. Liang, C. Workman, J. Lee et al., "Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II, " Journal of Immunology, vol. 180, no. 9, pp. 5916-5926, 2008.
39. S. G. Zheng, J. Wang, and D. A. Horwitz, "Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF- are resistant to Th17 conversion by IL-6, " Journal of Immunology, vol. 180, no. 11, pp. 7112-7116, 2008.
40. Q. Chen, Y. C. Kim, A. Laurence, G. A. Punkosdy, and E. M. Shevach, "IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo, " The Journal of Immunology, vol. 186, no. 11, pp. 6329-6337, 2011.